# US 5,352,823 A · Process for improving flow characteristics of crystalline ibuprofen

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,352,823 A
- Document ID: US5352823A
- Status: Granted
- Kind: A
- Application number: 07/963,872
- Filed: 1992-10-20
- Granted: 1994-10-04
- Earliest claimed: 1990-11-19
- Assignees: Albemarle Corporation
- Inventors: Lloyd E. Goddard; George A. Knesel
- Web page: https://patentgrep.com/patent/US5352823A

## CPC

- C07C 51/43: by change of the physical state, e.g. crystallisation
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

A process for producing crystalline ibuprofen having a crystal habit characterized by a particle length larger than 75 microns average and a length to width aspect ratio of greater than about 4 to 1 to about 5 to 1. The process involves crystallizing ibuprofen from a saturated solution of ibuprofen in a liquid hydrocarbon solvent by seeding and cooling such solution to a temperature of about 0.degree. C. to about -20.degree. C. at a rate to retard primary nucleation and promote secondary nucleation. The crystalline ibuprofen is separated from the slurry produced from such cooling.

## Claims

### Claim 1

In a process for preparing crystalline ibuprofen by forming a saturated solution of ibuprofen in a hydrocarbon solvent seeding such saturated solution with solid ibuprofen; and cooling the seeded saturated solution below the saturation point to effect crystallization and precipitating the crystalline ibuprofen from the solution thereof, the improvement comprising
(a) carrying out said cooling by reducing the temperature of said saturated solution in three sequential steps by about 5% in each step and holding said reduced temperature for about 10 minutes to about 180 minutes for each of said three sequential steps then reducing the temperature of the solution resulting from the third sequential step to about 0.degree. to about -20.degree., and
(b) precipitating crystalline ibuprofen having a crystal habit characterized by having a particle length larger than 150 microns average and a length to width aspect ratio of from about 4.1 to 1 to about 5 to 1.

### Claim 2 (depends on 1)

The process according to claim 1 wherein said liquid hydrocarbon is selected from the group consisting essentially of pentane, hexane, heptane, octane and mixtures thereof.

### Claim 3 (depends on 2)

The process according to claim 2 wherein said liquid hydrocarbon is hexane, heptane or mixtures thereof.

### Claim 4 (depends on 3)

The process according to claim 3 wherein said liquid hydrocarbon is hexane.

### Claim 5 (depends on 1)

The process according to claim 1 wherein said temperature of said saturated solution is about 30.degree. C. to about 50.degree. C.

### Claim 6 (depends on 5)

The process according to claim 5 wherein said temperature is about 40.degree. C. to about 45.degree. C.

### Claim 7 (depends on 1)

The process according to claim 1 wherein the amount of said seeding is about 0.01% to about 1.0% by weight of solid ibuprofen based on the total weight of solution.

### Claim 8 (depends on 7)

The process according to claim 7 wherein the amount of said seeding is about 0.015% to about 0.5% by weight.

### Claim 9 (depends on 8)

The process according to claim 8 wherein the amount of said seeding is about 0.02% to about 0.04% by weight.

### Claim 10 (depends on 1)

The process according to claim 1 wherein said saturated solution with solid ibuprofen is agitated.

### Claim 11 (depends on 1)

The process according to claim 1 wherein each one of said three sequentially lower temperatures is carried out over an interval of from about 20 minutes to about 120 minutes.

### Claim 12 (depends on 12)

The process according to claim 12 where each of said three sequentially lower temperatures is carried out over an interval of from about 45 minutes to about 75 minutes.